drugset / Trial / NCT03389555

Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial

NCT03389555 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

In this study, we aim to determine whether the combination of Ascorbic Acid (Vitamin C), Thiamine (Vitamin B1), and Corticosteroids improves the trajectory of organ failure and reduces mortality in patients with sepsis and septic shock as compared to placebo.

Timeline

Start
2018-02-09
Primary completion
2019-11-26
Completion
2020-02-28

Outcome

Missed primary endpoint

paper Overall, there was no statistically significant interaction between time and treatment group with regard to SOFA score over the 72 hours after enrollment PMID 32809003 ↗

paper adjusted mean difference, -0.8; 95% CI, -1.7 to 0.2; P = .12 for interaction PMID 32809003 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydrocortisone Other / unclassified 50 mg Intravenous
Subject Thiamine Other / unclassified 100 mg Intravenous
Subject Vitamin C Other / unclassified 1.5 g Intravenous